These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27457756)

  • 1. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis.
    Ueno KI; Shimojima Y; Kishida D; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2016 Dec; 19(12):1322-1330. PubMed ID: 27457756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.
    Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S
    BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
    Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
    Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
    Fujisawa T; Hozumi H; Kamiya Y; Kaida Y; Akamatsu T; Kusagaya H; Satake Y; Mori K; Mikamo M; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respirology; 2021 Apr; 26(4):370-377. PubMed ID: 33179395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
    Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
    Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis.
    Suzuka T; Kotani T; Takeuchi T; Fujiki Y; Hata K; Yoshida S; Shoda T; Makino S; Arawaka S
    Int J Rheum Dis; 2019 Feb; 22(2):303-313. PubMed ID: 30398034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
    Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.
    Matsubara S; Kondo K; Sugaya K; Miyamoto K
    Clin Rheumatol; 2012 Oct; 31(10):1493-8. PubMed ID: 22886003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early treatment in polymyositis and dermatomyositis.
    Naji P; Shahram F; Nadji A; Davatchi F
    Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
    Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
    Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
    Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
    Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of tacrolimus in patients with dermatomyositis/polymyositis: A meta-analysis and systematic review.
    Liao J; Peng X; Liu J; Xie X; Wang J
    Eur J Intern Med; 2023 Apr; 110():35-40. PubMed ID: 36725399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of FK506 on refractory inflammatory myopathies.
    Mitsui T; Kuroda Y; Ueno S; Kaji R
    Acta Neurol Belg; 2011 Sep; 111(3):188-94. PubMed ID: 22141281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
    Kuwana M; Wakasugi N; Furuya T; Uno S; Suda T
    J Rheumatol; 2022 Jul; 49(7):707-718. PubMed ID: 35428708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.